Delivery Order SPE2DB22D3501-SPE2DB26FTG67
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,228.56 to AmerisourceBergen Drug Corp for the supply of Cefazolin 2G/50ML in dextrose solution, with an ultimate completion date of August 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,638 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cefazolin 2 G/50 ML with dextrose solution, with an ultimate completion date of October 22, 2025. The award, issued on October 21, 2025, was made without a set-aside designation through open competition. This delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which carries a $999,999,999...
- The Defense Logistics Agency awarded a $10,147.43 delivery order to AmerisourceBergen Drug Corp for the supply of Cefazolin 2G/50ML with dextrose solution, with a firm fixed price and an ultimate completion date of September 29, 2025. This non-set-aside contract was competitively awarded and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a $1,630.47 delivery order to AmerisourceBergen Drug Corp for Cefazolin 2G/50ML-Dextroses, an antibiotic pharmaceutical product. The contract, issued on September 18, 2025, with an ultimate completion date of September 19, 2025, utilizes firm fixed pricing with no set-aside designation. Performance will take place at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is a child contract executed under AmerisourceBergen Drug Corp's...
- The U.S. Department of Defense Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,228.56 on August 27, 2025, for the supply of Cefazolin 2G/50ML with dextrose solution. This is a firm fixed price contract with no set-aside designation, competitively awarded to the prime contractor. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of August 28, 2025. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,457.12 to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Cefazolin 2G/50ML with dextrose solutions. This competitively awarded contract utilizes firm fixed-price terms with an ultimate completion date of September 9, 2025. The contract is non-set-aside and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,638.08 to AmerisourceBergen Drug Corp for the supply of Cefazolin 2 G/50 ML with dextrose solution, a commonly used antibiotic pharmaceutical product. The contract was competitively awarded on June 5, 2025, with an ultimate completion date of June 6, 2025, and reflects a firm fixed-price arrangement with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Cefazolin 2G/50ML with dextrose solution, valued at $1,228.56, with an ultimate completion date of September 25, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution...
- The Defense Logistics Agency awarded a delivery order valued at $1,228.56 to AmerisourceBergen Drug Corp for Cefazolin 2 G/50 ML-Dextrose, a pharmaceutical product used primarily as an antibiotic in military and federal healthcare settings. This competitively awarded, firm fixed-price delivery order is set to be completed by September 19, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $2,047.50 to AmerisourceBergen Drug Corp for the supply of Cefazolin 2 G/50 ML with Dextrose solution. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was executed on February 20, 2025, with an ultimate completion date of February 21, 2025. The product will be delivered to Conshohocken, Pennsylvania, which serves as the vendor's corporate headquarters location. This delivery order is issued under...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB26FTG67Delivery Order
The Defense Logistics Agency awarded a $1,638.00 delivery order to AmerisourceBergen Drug Corp for Cefazolin 2G/50ML with dextrose solutions, with an ultimate completion date of October 29, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, supplies pharmaceutical products and medical commodities to support military and veteran healthcare systems. As a prime contractor under the DLA Troop Support Medical IDC, the company fulfills delivery orders for a broad spectrum of therapeutic pharmaceuticals, including specialty medications, generic and brand-name drugs, vaccines, and medical supplies. This particular order for cefazolin—a broad-spectrum antibiotic commonly used in surgical prophylaxis and infection treatment—aligns with the company's extensive portfolio of antimicrobial agents supplied through its federal contract vehicle to support Defense Health Agency operations and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 10/28/25 |